Article
p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Feb 1996
De Benedetti V M, Travis L B, Welsh J A, van Leeuwen F E, Stovall M, Clarke E A, Boice J D, Bennett W P
Abstract excerpt
High risks of lung cancer occur after successful treatment of Hodgkin's disease. In addition to tobacco smoking, other risk factors include radiotherapy, chemotherapy, and immunosuppression, although the relative contributions of each are unknown. We conducted p53 mutational spectrum analysis in second lung cancers after radiation therapy for Hodgkin's disease in the Netherlands and in Ontario, Canada. Lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.